Neuroprotective Agents with Therapeutic Potential for COVID-19
COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID. Moderate symptoms include ageusia, anosmia, altered m...
Main Authors: | César A. Zaa, Clara Espitia, Karen L. Reyes-Barrera, Zhiqiang An, Marco A. Velasco-Velázquez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/11/1585 |
Similar Items
-
An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways
by: Xiangwen Tang, et al.
Published: (2023-10-01) -
Anthocyanins: Molecular Aspects on Their Neuroprotective Activity
by: César A. Zaa, et al.
Published: (2023-10-01) -
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
by: Haijian Wu, et al.
Published: (2015-09-01) -
Important Flavonoids and Their Role as a Therapeutic Agent
by: Asad Ullah, et al.
Published: (2020-11-01) -
The medicinal chemistry of Urtica dioica L.: from preliminary evidence to clinical studies supporting its neuroprotective activity
by: Prabhakar Semwal, et al.
Published: (2023-05-01)